-+ 0.00%
-+ 0.00%
-+ 0.00%

RedHill Biopharma sells 70% stake in Talicia Holdings to Apotex for USD 18 million upfront

PUBT·09/30/2026 20:24:23
Listen to the news
RedHill Biopharma sells 70% stake in Talicia Holdings to Apotex for USD 18 million upfront
  • RedHill Biopharma sold its 70% stake in Talicia Holdings to an Apotex unit for USD 18 million upfront.
  • Deal terms include up to USD 35 million in additional payments tied to worldwide net sales milestones.
  • Transaction closed on Aug. 27, 2026; a transition services agreement was signed as part of the handover.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Redhill Biopharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-004678), on September 30, 2026, and is solely responsible for the information contained therein.